chr1-163069254-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001102445.3(RGS4):c.61G>T(p.Ala21Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,549,568 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001102445.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGS4 | NM_001102445.3 | c.61G>T | p.Ala21Ser | missense_variant, splice_region_variant | 2/6 | NP_001095915.1 | ||
RGS4 | NM_001113381.1 | c.-231G>T | 5_prime_UTR_variant | 1/4 | NP_001106852.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGS4 | ENST00000421743.6 | c.61G>T | p.Ala21Ser | missense_variant, splice_region_variant | 2/6 | 1 | ENSP00000397181.2 | |||
RGS4 | ENST00000527393.5 | n.83G>T | splice_region_variant, non_coding_transcript_exon_variant | 2/5 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152026Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000313 AC: 48AN: 153360Hom.: 0 AF XY: 0.000420 AC XY: 34AN XY: 80910
GnomAD4 exome AF: 0.000122 AC: 171AN: 1397424Hom.: 2 Cov.: 33 AF XY: 0.000163 AC XY: 112AN XY: 689126
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.61G>T (p.A21S) alteration is located in exon 2 (coding exon 2) of the RGS4 gene. This alteration results from a G to T substitution at nucleotide position 61, causing the alanine (A) at amino acid position 21 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at